Mandy Ho‐Man Tam

Papers

Total Citations

H-Index

About

Mandy Ho‐Man Tam is a pioneering urological surgeon whose work centers on advancing minimally invasive techniques in robotic surgery and improving postoperative outcomes for prostate cancer patients. Her major contributions lie in preventing complications after robotic-assisted radical prostatectomy (RARP) and pelvic lymph node dissection. In her most cited work, a 2022 randomized controlled trial, Tam investigated the use of Hemopatch—a novel hemostatic patch—to prevent lymphatic leaks, a common and debilitating complication. This prospective, single-center phase III study demonstrated her commitment to evidence-based innovation, directly addressing a critical gap in urological care. Tam’s research also extends to complex reconstructive procedures, as shown in her 2019 study on robotic ileal interposition for long ureteric strictures, showcasing her technical expertise in managing challenging urological pathologies. With citations highlighting the clinical relevance of her work, Tam has established herself as a leader in robotic urology, blending rigorous trial design with surgical precision to enhance patient recovery. Her achievements underscore a dedication to translating novel technologies into tangible improvements in surgical safety and quality of life, making her a notable figure in the field of urological oncology and robotic surgery.